Filing Flows › Comparisons › SCNX vs IGC
Scienture Holdings vs IGC Pharma: SCNX and IGC compared
Scienture Holdings is the larger company: $344K of revenue in its latest quarter (Q2 2026) against $328K for IGC Pharma (Q3 2026). IGC Pharma is more profitable, with an operating margin of -588.7% against -785.6%.
Where the money goes: SCNX and IGC
Scienture Holdings (SCNX) · Q2 2026
Scienture Holdings, Q2 2026: revenue $344K, operating margin -785.6%, net loss $2.8M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
IGC Pharma (IGC) · Q3 2026
IGC Pharma, Q3 2026: revenue $328K (+72% year over year), operating margin -588.7%, net loss $2.0M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Scienture Holdings (SCNX) | IGC Pharma (IGC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $344K | $328K |
| Revenue growth, Y/Y | — | +72% |
| Operating margin | -785.6% | -588.7% |
| Net earnings | −$2.8M | −$2.0M |
| Net margin | -821.3% | -623.8% |
| Operating cash flow | −$3.1M | −$1.4M |
Where the revenue comes from
IGC Pharma
- White Labeling Services: $321K (98%)
- Wellness and Lifestyle: $7K (2%)
Questions
Which is bigger, Scienture Holdings or IGC Pharma?
Scienture Holdings is the larger company: $344K of revenue in its latest quarter (Q2 2026) against $328K for IGC Pharma (Q3 2026).
Is Scienture Holdings or IGC Pharma growing faster?
IGC Pharma is more profitable, with an operating margin of -588.7% against -785.6%.
More: Scienture Holdings earnings · how Scienture Holdings makes money · IGC Pharma earnings · how IGC Pharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.